P&G names Jimenez, Peltz to board after proxy fight
CINCINNATI — After a lengthy proxy battle, Procter & Gamble Co. has named Novartis chief executive officer Joseph Jimenez and activist investor Nelson Peltz as directors. Jimenez and Peltz, co-founder of Trian Fund Management, are slated to join the board on March 1. Their additions will expand the P&G board from 11 to 13 members.
